RB

Ramesh Babu Sarvisetty

Active Director Whole-Time Director DIN 01167790
DIN 01167790 First appointment Aug 1998 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Total affiliations 7 Since Aug 1998
Shareholding value •••• Premium profile

About Ramesh Babu Sarvisetty

Data last updated:

Ramesh Babu Sarvisetty is a Whole-Time Director at Vital Therapeutics Private Limited (since 1998), Whole-Time Director at Vital Therapeutics And Formulations Private Limited (since 2004) and Director at Parakite Builders Private Limited (since 2016), and holds 4 more current directorships. The companies operate in Pharma and Real Estate and Construction. The 5 current companies with reported revenue have a combined latest revenue of ₹297 Cr; the largest is Vital Therapeutics Private Limited at ₹145 Cr (FY 2025).

DIN 01167790
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 04 Aug 1998
Oldest Company Age 28 yrs
Largest company Vital Therapeutics Private Limited · ₹145 Cr (FY 2025)
Combined revenue ₹297 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vital Therapeutics Private Limited U24110TG1998PTC029876
Whole-Time Director04 Aug 19981998₹145 Cr (FY 2025)Active
Whole-Time Director25 Feb 20042004₹75.95 Cr (FY 2024)Active
Parakite Builders Private Limited U45309KA2016PTC098163
Director09 Dec 20162016₹46.63 Cr (FY 2024)Active
Pellsys Pharma Private Limited U24233TG2008PTC062293
Whole-Time Director09 Jul 20132008₹29.54 Cr (FY 2025)Active
Mondo Builders Private Limited U45309KA2017PTC099466
Director30 Jan 20172017₹18.2 Lakh (FY 2025)Active
Partner28 Aug 20232023Active
Partner18 Dec 20172016Active

Directorship timeline

Open interactive timeline →
Vital Therapeutics Private Limited
Pellsys Pharma Private Limited
Vital Therapeutics And Formulations Private Limited
Parakite Builders Private Limited
Premium access

Shareholding and investment profile for Ramesh Babu Sarvisetty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramesh Babu Sarvisetty

Ramesh Babu Sarvisetty currently holds 7 directorships: Vital Therapeutics Private Limited (Whole-Time Director, since 04 Aug 1998, revenue ₹145 Cr (FY 2025)); Vital Therapeutics And Formulations Private Limited (Whole-Time Director, since 25 Feb 2004, revenue ₹75.95 Cr (FY 2024)); Parakite Builders Private Limited (Director, since 09 Dec 2016, revenue ₹46.63 Cr (FY 2024)); Pellsys Pharma Private Limited (Whole-Time Director, since 09 Jul 2013, revenue ₹29.54 Cr (FY 2025)); Mondo Builders Private Limited (Director, since 30 Jan 2017, revenue ₹18.2 Lakh (FY 2025)); and 2 more.

Ramesh Babu Sarvisetty was first appointed on 04 Aug 1998 as Whole-Time Director at Vital Therapeutics Private Limited. The most recent appointment on record is 28 Aug 2023 at Nirvana Homespaces Llp.

The 5 current companies of Ramesh Babu Sarvisetty that report revenue have a combined latest revenue of ₹297 Cr: Vital Therapeutics Private Limited ₹145 Cr (FY 2025); Vital Therapeutics And Formulations Private Limited ₹75.95 Cr (FY 2024); Parakite Builders Private Limited ₹46.63 Cr (FY 2024); Pellsys Pharma Private Limited ₹29.54 Cr (FY 2025); Mondo Builders Private Limited ₹18.2 Lakh (FY 2025).

The current boards of Ramesh Babu Sarvisetty's companies include Venugopal Setty Sarvisetty (Vital Therapeutics Private Limited), Avinash Agarwal (Parakite Builders Private Limited), Gangavaram Pulla Reddy (Parakite Builders Private Limited), Mahabir Prasad Agrawall (Parakite Builders Private Limited), Pratap Reddy Vallur (Parakite Builders Private Limited), Cherupalli Ganesh (Pellsys Pharma Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available